Posted by jrbecker76 on August 13, 2014, at 16:07:13
Suvorexant will undoubtedly be an interesting new drug in the hypnotic category given that it represents an entirely new class known as orexin antagonists. However, there should be some caution in prescribing it to those with co-morbid psychiatric diagnoses. In clinical trials, suvorexant subjects were found to have a slightly higher but significant incidence of suicidal ideation (but not depression) in comparison with placebo. Further consumer experience once it launches will hopefully provide more insight on this risk.